Last Updated: November 13, 2026

Details for New Drug Application (NDA): 206404

« Back to Dashboard

NDA 206404 describes PENTOBARBITAL SODIUM, which is a drug marketed by Lannett, Vitarine, Whiteworth Town Plsn, Bpi Labs, Elkins Sinn, Hikma, and Sagent Pharms Inc, and is included in nine NDAs. It is available from two suppliers. Additional details are available on the PENTOBARBITAL SODIUM profile page.

The generic ingredient in PENTOBARBITAL SODIUM is pentobarbital sodium. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.

Summary for 206404

Tradename:	PENTOBARBITAL SODIUM
Applicant:	Sagent Pharms Inc
Ingredient:	pentobarbital sodium
Patents:	0

Suppliers and Packaging for NDA: 206404

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PENTOBARBITAL SODIUM	pentobarbital sodium	INJECTABLE;INJECTION	206404	ANDA	Sagent Pharmaceuticals	25021-676	25021-676-20	1 VIAL in 1 CARTON (25021-676-20) / 20 mL in 1 VIAL
PENTOBARBITAL SODIUM	pentobarbital sodium	INJECTABLE;INJECTION	206404	ANDA	Sagent Pharmaceuticals	25021-676	25021-676-50	1 VIAL in 1 CARTON (25021-676-50) / 50 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	50MG/ML
Approval Date:	May 23, 2016	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.